These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29520276)

  • 1. Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing.
    Arrieta-Bolaños E; Crivello P; Metzing M; Meurer T; Ahci M; Rytlewski J; Vignali M; Yusko E; van Balen P; Horn PA; Falkenburg JHF; Fleischhauer K
    Front Immunol; 2018; 9():280. PubMed ID: 29520276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allorecognition of HLA-DP by CD4+ T cells is affected by polymorphism in its alpha chain.
    Lauterbach N; Crivello P; Wieten L; Zito L; Groeneweg M; Voorter CE; Fleischhauer K; Tilanus MG
    Mol Immunol; 2014 May; 59(1):19-29. PubMed ID: 24462895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM.
    Meurer T; Crivello P; Metzing M; Kester M; Megger DA; Chen W; van Veelen PA; van Balen P; Westendorf AM; Homa G; Layer SE; Turki AT; Griffioen M; Horn PA; Sitek B; Beelen DW; Falkenburg JHF; Arrieta-Bolaños E; Fleischhauer K
    Blood; 2021 Feb; 137(7):923-928. PubMed ID: 33025005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DPB1 mismatching results in the generation of a full repertoire of HLA-DPB1-specific CD4+ T cell responses showing immunogenicity of all HLA-DPB1 alleles.
    Rutten CE; van Luxemburg-Heijs SA; van der Meijden ED; Griffioen M; Oudshoorn M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1282-92. PubMed ID: 20350610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting Genetic Control of HLA-DPB1 Expression and Its Relation to Structural Mismatch Models in Hematopoietic Stem Cell Transplantation.
    Meurer T; Arrieta-Bolaños E; Metzing M; Langer MM; van Balen P; Falkenburg JHF; Beelen DW; Horn PA; Fleischhauer K; Crivello P
    Front Immunol; 2018; 9():2236. PubMed ID: 30344521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation.
    Zino E; Frumento G; Marktel S; Sormani MP; Ficara F; Di Terlizzi S; Parodi AM; Sergeant R; Martinetti M; Bontadini A; Bonifazi F; Lisini D; Mazzi B; Rossini S; Servida P; Ciceri F; Bonini C; Lanino E; Bandini G; Locatelli F; Apperley J; Bacigalupo A; Ferrara GB; Bordignon C; Fleischhauer K
    Blood; 2004 Feb; 103(4):1417-24. PubMed ID: 14576061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation.
    Crivello P; Zito L; Sizzano F; Zino E; Maiers M; Mulder A; Toffalori C; Naldini L; Ciceri F; Vago L; Fleischhauer K
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):233-41. PubMed ID: 25445022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective T cell receptor Vbeta gene usage by alloreactive T cells responding to defined HLA-DR alleles.
    Lobashevsky A; Kotb M; Gaber AO
    Transplantation; 1996 Nov; 62(9):1332-40. PubMed ID: 8932281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactive feature of HLA-DP-specific cytotoxic T-cell clone.
    Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
    Cell Immunol; 1994 Jan; 153(1):262-70. PubMed ID: 7904540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying size and diversity of the human T cell alloresponse.
    DeWolf S; Grinshpun B; Savage T; Lau SP; Obradovic A; Shonts B; Yang S; Morris H; Zuber J; Winchester R; Sykes M; Shen Y
    JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells.
    Kobayashi H; Kimura S; Aoki N; Sato K; Celis E; Katagiri M
    Immunogenetics; 2001 Oct; 53(8):626-33. PubMed ID: 11797095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DPbeta residue 69 plays a crucial role in allorecognition.
    Díaz G; Catálfamo M; Coiras MT; Alvarez AM; Jaraquemada D; Nombela C; Sánchez-Pérez M; Arroyo J
    Tissue Antigens; 1998 Jul; 52(1):27-36. PubMed ID: 9714471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell receptor beta-chain usage in directly activated alloreactive CD4+ T cells: unrestricted Vbeta gene usage with CDR3 size limitations.
    Zhai Y; Kupiec-Weglinski JW
    Transplantation; 2003 Feb; 75(4):514-21. PubMed ID: 12605120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive correlation between oligonucleotide typing and T-cell recognition of HLA-DP molecules.
    de Koster HS; Kenter MJ; D'Amaro J; Luiten RM; Schroeijers WE; Giphart MJ; Termijtelen A
    Immunogenetics; 1991; 34(1):12-22. PubMed ID: 1713190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significantly higher frequencies of alloreactive CD4+ T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities.
    Sizzano F; Zito L; Crivello P; Crocchiolo R; Vago L; Zino E; Fleischhauer K
    Blood; 2010 Sep; 116(11):1991-2. PubMed ID: 20847212
    [No Abstract]   [Full Text] [Related]  

  • 17. Mismatched HLA-DRB3 Can Induce a Potent Immune Response After HLA 10/10 Matched Stem Cell Transplantation.
    van Balen P; van Luxemburg-Heijs SAP; van de Meent M; van Bergen CAM; Halkes CJM; Jedema I; Falkenburg JHF
    Transplantation; 2017 Dec; 101(12):2850-2854. PubMed ID: 28252558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia.
    Rutten CE; van Luxemburg-Heijs SA; Griffioen M; Marijt EW; Jedema I; Heemskerk MH; Posthuma EF; Willemze R; Falkenburg JH
    Leukemia; 2008 Jul; 22(7):1387-94. PubMed ID: 18418406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transduction of an HLA-DP4-restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes.
    Zhao Y; Zheng Z; Khong HT; Rosenberg SA; Morgan RA
    J Immunother; 2006; 29(4):398-406. PubMed ID: 16799335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DPB1 Reactive T Cell Receptors for Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation.
    Klobuch S; Hammon K; Vatter-Leising S; Neidlinger E; Zwerger M; Wandel A; Neuber LM; Heilmeier B; Fichtner R; Mirbeth C; Herr W; Thomas S
    Cells; 2020 May; 9(5):. PubMed ID: 32443793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.